These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33326304)

  • 1. Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke.
    Freixa-Pamias R; Blanch Gràcia P; Rodríguez Latre ML; Basile L; Sanchez Chamero P; Gomez-Choco M; Armario P; Martínez-Rubio A; Lupón J;
    Curr Med Res Opin; 2021 Mar; 37(3):357-365. PubMed ID: 33326304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Liu J; Wang Y; Guo W; Cheng Y; Zhang S; Wu B; Liu M
    Int J Cardiol; 2021 Jan; 322():258-264. PubMed ID: 32814110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England.
    Bakhai A; Petri H; Vahidnia F; Wolf C; Ding Y; Foskett N; Sculpher M
    J Eval Clin Pract; 2021 Feb; 27(1):119-133. PubMed ID: 32314853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
    Chang KW; Xian Y; Zhao X; Mi X; Matsouaka R; Schwamm LH; Shah S; Lytle BL; Smith EE; Bhatt DL; Fonarow GC; Hsu JC
    Int J Cardiol; 2020 Dec; 321():88-94. PubMed ID: 32805327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event.
    Jung YH; Kim YD; Kim J; Han SW; Lee KY
    PLoS One; 2018; 13(12):e0209198. PubMed ID: 30566502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.
    Hohnloser SH; Basic E; Nabauer M
    Clin Res Cardiol; 2019 Sep; 108(9):1042-1052. PubMed ID: 30771066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
    Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
    Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019.
    Gorczyca-Głowacka I; Bielecka B; Wałek P; Chrapek M; Ciba-Stemplewska A; Jelonek O; Kot A; Czyżyk A; Pióro M; Major A; Wożakowska-Kapłon B
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.